Document is current
Any future updates will be listed below
-
Authors
Jurkowicz, Menucha https://orcid.org/0009-0008-7167-384X
Margalit, Ili
Harris, Itai
Mazar, Daniel
Teper, Arad
Royzman, Irena
Uppal, Sonal
Liang, Caihua
Begier, Elizabeth
Ganiel, Imri
Yahav, Dafna
Mandelboim, Michal
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 18 September 2025
Accepted: 16 December 2025
First Online: 26 March 2026
Declarations
:
: Dafna Yahav is conducting an investigator-initiated study supported by Shionogi (funding to the institution). Dafna Yahav is an Editorial Board member of Infectious Diseases and Therapy , but was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Menucha Jurkowicz, Ili Margalit, Itai Harris, Daniel Mazar, Arad Teper, Irena Royzman, Sonal Uppal, Caihua Liang, Elizabeth Begier, Imri Ganiel & Michal Mandelboim have nothing to disclose.
: The study was approved by Sheba Medical Center’s institutional review board (approval no. SMC-0218-23), and was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All data were fully anonymized prior to analysis, with no identifiable patient information retained. The institutional review board granted a waiver of informed consent, as the study involved analysis of de-identified data and posed minimal risk to participants.
